Diabetes Research Center member Yumi Imai, MD received a four-year $710,000 VA Merit Award. Imai will continue to build on previous research to investigate type 2 diabetes treatment by identifying correlations between lipolysis and beta cell dysfunction.
Previously, Imai has found that lipolysis is able to mobilize fats in tissue islets affected by type 2 diabetes and beta cell dysfunction. These studies suggest that dysfunctional pancreatic beta cells contribute to type 2 diabetes; however, the mechanism behind the decline in the function of these cells is still unknown. Imai’s new research will assist with the understanding of the pancreatic beta cell failure.
Diabetes Center News Hub 